Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jutta Gaertner"'
Autor:
Tanuja Chitnis, Angelo Ghezzi, Kumaran Deiva, Peter Huppke, Brenda Banwell, Lauren Krupp, Emmanuelle Waubant, Jutta Gaertner, Virginia DeLasHeras, Amin Azmon, Rajesh Karan
Publikováno v:
BMJ Neurology Open, Vol 4, Iss 1 (2022)
Background In the PARADIGMS Study, fingolimod demonstrated superior efficacy versus interferon (IFN) β-1a and comparable overall incidence of adverse events but slightly higher rate of serious adverse events in patients with paediatric-onset multipl
Externí odkaz:
https://doaj.org/article/860df43c8cbd41c3b813a5753b7ea96d
Autor:
Lars Schlotawa, Matthias Kettwig, Rebecca Ahrens-Nicklas, Matthias Baud, Nicola Brunetti-Pierri, Alyssa Gagne, Sophie Schroeder, Jilenia Monfregula, Tonatiuh Pena, Karthikeyan Radhakrishnan, Elisa A. Waxman, André Fischer, Deborah L. French, Michael H. Gelb, Jutta Gaertner
Publikováno v:
Molecular Genetics and Metabolism. 138:107308
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80d449e04d4d412257a42409db312ac6
https://doi.org/10.1016/j.ymgme.2022.107308
https://doi.org/10.1016/j.ymgme.2022.107308
Autor:
Lauren Krupp, Brenda Banwell, Tanuja Chitnis, Kumaran Deiva, Jutta Gaertner, Angelo Ghezzi, Peter Huppke, Emmanuelle Waubant, Virginia DeLasHeras, Amin Azmon, Rajesh Karan
Publikováno v:
BMJ neurology open. 4(1)
BackgroundIn the PARADIGMS Study, fingolimod demonstrated superior efficacy versus interferon (IFN) β-1a and comparable overall incidence of adverse events but slightly higher rate of serious adverse events in patients with paediatric-onset multiple
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bfd8e5e32aa3f994c6afad260a72ad2
https://pubmed.ncbi.nlm.nih.gov/35308898
https://pubmed.ncbi.nlm.nih.gov/35308898
Autor:
Adeline Vanderver, Florian Eichler, Nicola Brunetti-Pierri, Mauricio De Castro, Giancarlo Parenti, Joerg Klepper, Andrea Ballabio, Alan Finglas, Marcus Lee, Thomas Dierks, Brian Kirmse, Jutta Gaertner, Lars Schlotawa, Laura Adang, Amber Olsen, Rebecca C. Ahrens-Nicklas, Arastoo Vossough, Can Ficicioglu
Publikováno v:
Molecular genetics and metabolism. 123(3)
Multiple sulfatase deficiency (MSD) is an ultra-rare neurodegenerative disorder that results in defective sulfatase post-translational modification. Sulfatases in the body are activated by a unique protein, formylglycine-generating enzyme (FGE) that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f96fc1c9b41283295cc10567a686079f
https://pubmed.ncbi.nlm.nih.gov/29397290
https://pubmed.ncbi.nlm.nih.gov/29397290
Autor:
Peter Huppke, Friedrich Ebinger, Alexandra Fuerwentsches, Alexander Schwarz, Benedikt Fritzsching, Bettina Balint, Brigitte Wildemann, Friedemann Paul, Jutta Gaertner, Juergen Haas, Ulrich Seidel
Publikováno v:
Neurology. 78:P02.126-P02.126
Objective: To compare the peripheral B-cell compartment as to distribution of B-cell subpopulations with regard to clinical activity and effects of disease modifying drugs (DMD) in pediatric-onset relapsing-remitting Multiple Sclerosis (RRMS) and adu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77015b4de785dacbbd815eb8ce5bbf40
https://doi.org/10.1212/wnl.78.1_meetingabstracts.p02.126
https://doi.org/10.1212/wnl.78.1_meetingabstracts.p02.126